SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Morepen Laboratories submits first U.S. ANDA for sitagliptin tablets USP in three strengths

The filing covers three strengths of sitagliptin tablets USP.

MORL.NS